Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities.
暂无分享,去创建一个
[1] Y. Zhang,et al. The Angelman syndrome protein Ube3a regulates synapse development by ubiquitinating Tkv in Drosophila , 2013 .
[2] J. Christodoulou,et al. MECP2-Related Disorders , 2012 .
[3] H. Van Esch. MECP2 Duplication Syndrome , 2011, Molecular Syndromology.
[4] M. Sahin,et al. TSC1/TSC2 signaling in the CNS , 2011, FEBS letters.
[5] M. Sahin,et al. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. , 2011, Current opinion in neurology.
[6] C. Betancur,et al. Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting , 2011, Brain Research.
[7] Laurent Mottron,et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia , 2011, Human Genetics.
[8] E. Thiele,et al. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex , 2011, Neurology.
[9] M. Giustetto,et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. , 2011, Human molecular genetics.
[10] G. Feng,et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.
[11] M. Bear,et al. New views of Arc, a master regulator of synaptic plasticity , 2011, Nature Neuroscience.
[12] A. Jauch,et al. De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation , 2011, European Journal of Human Genetics.
[13] J. Hablitz,et al. Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. , 2011, Journal of neurophysiology.
[14] Alcino J. Silva,et al. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. , 2011, Trends in molecular medicine.
[15] Mark F Bear,et al. Toward fulfilling the promise of molecular medicine in fragile X syndrome. , 2011, Annual review of medicine.
[16] Janice Branson,et al. Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056 , 2011, Science Translational Medicine.
[17] P. D. Vries,et al. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex , 2010, Neurotherapeutics.
[18] R. Hagerman,et al. Fragile X: Leading the way for targeted treatments in autism , 2010, Neurotherapeutics.
[19] Mark J. Harris,et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication , 2010, Molecular autism.
[20] B. Philpot,et al. Angelman syndrome: advancing the research frontier of neurodevelopmental disorders , 2010, Journal of Neurodevelopmental Disorders.
[21] W. Kaufmann,et al. Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.
[22] M. Bear,et al. Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome , 2010, The Journal of Neuroscience.
[23] Fred H. Gage,et al. A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.
[24] Rodney C. Samaco,et al. GABAergic dysfunction mediates autism-like stereotypies and Rett syndrome phenotypes , 2010, Nature.
[25] B. Oostra,et al. Potential therapeutic interventions for fragile X syndrome. , 2010, Trends in molecular medicine.
[26] T. Jongens,et al. Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention , 2010, Disease Models & Mechanisms.
[27] Mika Nakamoto,et al. Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome , 2010, The Journal of Neuroscience.
[28] Tatiana Nikitina,et al. MeCP2 Binds Cooperatively to Its Substrate and Competes with Histone H1 for Chromatin Binding Sites , 2010, Molecular and Cellular Biology.
[29] W. Kaufmann,et al. Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome , 2010, The Journal of Neuroscience.
[30] J. Arunachalam,et al. MeCP2270 Mutant Protein Is Expressed in Astrocytes as well as in Neurons and Localizes in the Nucleus , 2010, Cytogenetic and Genome Research.
[31] Allen D. Delaney,et al. Conserved Role of Intragenic DNA Methylation in Regulating Alternative Promoters , 2010, Nature.
[32] Ute Moog,et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation , 2010, Nature Genetics.
[33] D. Kunze,et al. Exogenous Brain-Derived Neurotrophic Factor Rescues Synaptic Dysfunction in Mecp2-Null Mice , 2010, The Journal of Neuroscience.
[34] Izumi Maezawa,et al. Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate , 2010, The Journal of Neuroscience.
[35] Marie-Pierre Dubé,et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia , 2010, Proceedings of the National Academy of Sciences.
[36] Yiping Shen,et al. Deletions of NRXN1 (Neurexin-1) Predispose to a Wide Spectrum of Developmental Disorders , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[37] M. Sur,et al. Loss of Arc renders the visual cortex impervious to the effects of sensory experience or deprivation , 2010, Nature Neuroscience.
[38] M. Stryker,et al. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a , 2010, Proceedings of the National Academy of Sciences.
[39] Z. Ou,et al. Deletion Syndrome : Clinical and Molecular Analysis Using Array CGH , 2010 .
[40] Alan R. Mardinly,et al. The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc , 2010, Cell.
[41] Robert S. Illingworth,et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. , 2010, Molecular cell.
[42] P. Stankiewicz,et al. Structural variation in the human genome and its role in disease. , 2010, Annual review of medicine.
[43] Mustafa Sahin,et al. Tsc2-Rheb Signaling Regulates EphA-Mediated Axon Guidance , 2009, Nature Neuroscience.
[44] O. Paulsen,et al. The roles of GABAB receptors in cortical network activity. , 2010, Advances in pharmacology.
[45] P. D. de Vries. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. , 2010, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.
[46] Rodney C. Samaco,et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities , 2009, Proceedings of the National Academy of Sciences.
[47] J. Lupski,et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome , 2009, Annals of neurology.
[48] C. Barthélémy,et al. Autism and Nonsyndromic Mental Retardation Associated with a De Novo Mutation in the NLGN4X Gene Promoter Causing an Increased Expression Level , 2009, Biological Psychiatry.
[49] Annette Schenck,et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. , 2009, American journal of human genetics.
[50] J. LaSalle,et al. Evolving role of MeCP2 in Rett syndrome and autism. , 2009, Epigenomics.
[51] S. Auvin,et al. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations , 2009, Journal of Medical Genetics.
[52] David R. Hampson,et al. Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures , 2009, Molecular Pharmacology.
[53] R. Prakash,et al. Ube3a is required for experience-dependent maturation of the neocortex , 2009, Nature Neuroscience.
[54] J. Frahm,et al. Neuroligin‐3‐deficient mice: model of a monogenic heritable form of autism with an olfactory deficit , 2009, Genes, brain, and behavior.
[55] E. Masliah,et al. Widespread changes in dendritic and axonal morphology in Mecp2‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks , 2009, The Journal of comparative neurology.
[56] D. Harvey,et al. Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions , 2009, The Journal of Neuroscience.
[57] H. Covington,et al. MeCP2-Mediated Transcription Repression in the Basolateral Amygdala May Underlie Heightened Anxiety in a Mouse Model of Rett Syndrome , 2009, The Journal of Neuroscience.
[58] R. Jaenisch,et al. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function , 2009, Proceedings of the National Academy of Sciences.
[59] G. Mandel,et al. Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology , 2009, Nature Neuroscience.
[60] Elvira Bramon,et al. Disruption of the neurexin 1 gene is associated with schizophrenia. , 2009, Human molecular genetics.
[61] Wei Zhang,et al. Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.
[62] Nathan R. Wilson,et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice , 2009, Proceedings of the National Academy of Sciences.
[63] Michael P. Stryker,et al. Reversing Neurodevelopmental Disorders in Adults , 2008, Neuron.
[64] Mark F. Bear,et al. The Autistic Neuron: Troubled Translation? , 2008, Cell.
[65] T. Südhof. Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.
[66] Michelle N. Ngo,et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model , 2008, Journal of Medical Genetics.
[67] Huda Y. Zoghbi,et al. Deletion of Mecp2 in Sim1-Expressing Neurons Reveals a Critical Role for MeCP2 in Feeding Behavior, Aggression, and the Response to Stress , 2008, Neuron.
[68] Alcino J. Silva,et al. Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.
[69] Ravinesh A. Kumar,et al. Novel Submicroscopic Chromosomal Abnormalities Detected in Autism Spectrum Disorder , 2008, Biological Psychiatry.
[70] Stephen T. C. Wong,et al. MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.
[71] M. C. Phelan. Orphanet Journal of Rare Diseases BioMed Central Review Deletion 22q13.3 syndrome , 2008 .
[72] Mustafa Sahin,et al. Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function , 2008, The Journal of Neuroscience.
[73] S. Sommer,et al. Familial deletion within NLGN4 associated with autism and Tourette syndrome , 2008, European Journal of Human Genetics.
[74] D. Geschwind,et al. Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.
[75] H. Zoghbi,et al. Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome , 2008, Neurology.
[76] A. Sawa,et al. [Neurodevelopmental disturbance in the pathogenesis of major mental disorders]. , 2008, Brain and nerve = Shinkei kenkyu no shinpo.
[77] Daniela C. Zarnescu,et al. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. , 2008, Nature chemical biology.
[78] Liang Zhang,et al. The MeCP2‐null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability , 2008, Hippocampus.
[79] Mark F Bear,et al. Smaller Dendritic Spines, Weaker Synaptic Transmission, but Enhanced Spatial Learning in Mice Lacking Shank1 , 2008, The Journal of Neuroscience.
[80] Jens Frahm,et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism , 2008, Proceedings of the National Academy of Sciences.
[81] Yiping Shen,et al. Disruption of neurexin 1 associated with autism spectrum disorder. , 2008, American journal of human genetics.
[82] M. Missler,et al. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. , 2008, Journal of neurophysiology.
[83] Mark F. Bear,et al. Correction of Fragile X Syndrome in Mice , 2007, Neuron.
[84] J M Friedman,et al. A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1α , 2007, Journal of Medical Genetics.
[85] M. Bieda,et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes , 2007, Proceedings of the National Academy of Sciences.
[86] Christian R Marshall,et al. Contribution of SHANK3 mutations to autism spectrum disorder. , 2007, American journal of human genetics.
[87] J. Inazawa,et al. 22q13 microduplication in two patients with common clinical manifestations: A recognizable syndrome? , 2007, American journal of medical genetics. Part A.
[88] J. Cheadle,et al. Cognitive deficits in Tsc1+/−mice in the absence of cerebral lesions and seizures , 2007, Annals of neurology.
[89] Huda Y. Zoghbi,et al. The Story of Rett Syndrome: From Clinic to Neurobiology , 2007, Neuron.
[90] Jacqueline Blundell,et al. A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice , 2007, Science.
[91] Christian Rosenmund,et al. MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number , 2007, Neuron.
[92] H. Zoghbi,et al. Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.
[93] T. Südhof,et al. Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2 , 2007, Neuron.
[94] U. Francke,et al. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets , 2007, BMC Medical Genetics.
[95] A. Bird,et al. Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.
[96] R. Jaenisch,et al. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2 , 2007, Proceedings of the National Academy of Sciences.
[97] M. Bear,et al. Activity-dependent regulation of NR2B translation contributes to metaplasticity in mouse visual cortex , 2007, Neuropharmacology.
[98] Thomas Bourgeron,et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.
[99] E. Weeber,et al. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation , 2007, Nature Neuroscience.
[100] Ankita Patel,et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males , 2006, Genetics in Medicine.
[101] Eric C. Griffith,et al. Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation , 2006, Neuron.
[102] Thomas C. Südhof,et al. Neuroligins Determine Synapse Maturation and Function , 2006, Neuron.
[103] G. Baird,et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) , 2006, The Lancet.
[104] P. Huppke,et al. Very mild cases of Rett syndrome with skewed X inactivation , 2006, Journal of Medical Genetics.
[105] Amy Brand,et al. CROSSREF , 2006 .
[106] P. Tam,et al. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. , 2006, Brain : a journal of neurology.
[107] R. Jaenisch,et al. Postnatal Loss of Methyl-CpG Binding Protein 2 in the Forebrain is Sufficient to Mediate Behavioral Aspects of Rett Syndrome in Mice , 2006, Biological Psychiatry.
[108] S. Nelson,et al. The Disease Progression of Mecp2 Mutant Mice Is Affected by the Level of BDNF Expression , 2006, Neuron.
[109] H. Beck,et al. Impaired synaptic plasticity in a rat model of tuberous sclerosis , 2006, The European journal of neuroscience.
[110] James H. Eubanks,et al. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome , 2006, Neurobiology of Disease.
[111] H. Zoghbi,et al. Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome , 2006, The Journal of Neuroscience.
[112] J. Gécz,et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. , 2005, American journal of human genetics.
[113] B. Hagberg. Rett Syndrome: Long-Term Clinical Follow-Up Experiences Over Four Decades , 2005, Journal of child neurology.
[114] Rudolf Jaenisch,et al. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[115] A. Bird,et al. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. , 2005, Human molecular genetics.
[116] C. B. Smith,et al. Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.
[117] Lu Chen,et al. Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[118] P. Worley,et al. Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons , 2005, The Journal of Neuroscience.
[119] Johan T den Dunnen,et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.
[120] G. Edelman,et al. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[121] K. Hameister,et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome , 2005, Journal of Medical Genetics.
[122] Ann Marie Craig,et al. Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins , 2004, Cell.
[123] Noriyuki Kishi,et al. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions , 2004, Molecular and Cellular Neuroscience.
[124] H. Zoghbi,et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. , 2004, Human molecular genetics.
[125] Mark F Bear,et al. The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.
[126] Albert David,et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. , 2004, American journal of human genetics.
[127] Eric C. Griffith,et al. Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.
[128] Daisuke Hattori,et al. DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.
[129] H. McDermid,et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms , 2003, Journal of medical genetics.
[130] T. Südhof,et al. α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.
[131] Thomas Bourgeron,et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.
[132] R. Jaenisch,et al. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[133] R. Tuchman,et al. Epilepsy in autism , 2002, The Lancet Neurology.
[134] Juan I. Young,et al. Mice with Truncated MeCP2 Recapitulate Many Rett Syndrome Features and Display Hyperacetylation of Histone H3 , 2002, Neuron.
[135] T. Südhof,et al. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. , 2002, Genomics.
[136] E. Blennow,et al. FISH-mapping of a 100-kb terminal 22q13 deletion , 2002, Human Genetics.
[137] S. Klauck,et al. A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. , 2002, American journal of human genetics.
[138] H. Zoghbi,et al. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. , 2002, Human molecular genetics.
[139] D. Cohen,et al. MECP2 mutation in a boy with language disorder and schizophrenia. , 2002, The American journal of psychiatry.
[140] J. LaSalle,et al. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation , 2002, Journal of Molecular Medicine.
[141] Stephen T Warren,et al. A decade of molecular studies of fragile X syndrome. , 2002, Annual review of neuroscience.
[142] A. Renieri,et al. Preserved speech variants of the Rett syndrome: molecular and clinical analysis. , 2001, American journal of medical genetics.
[143] R. Borgatti,et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. , 2001, American journal of human genetics.
[144] Guosong Liu,et al. Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer , 2001, Neuron.
[145] I. Weiler,et al. Synaptic regulation of protein synthesis and the fragile X protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[146] H. McDermid,et al. 22q13 deletion syndrome. , 2001, American journal of medical genetics.
[147] R. Jaenisch,et al. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.
[148] A. Bird,et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.
[149] W. Greenough,et al. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. , 2000, Cerebral cortex.
[150] R. Fetter,et al. Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons , 2000, Cell.
[151] D. Richter,et al. Somatostatin Receptor Interacting Protein Defines a Novel Family of Multidomain Proteins Present in Human and Rodent Brain* , 1999, The Journal of Biological Chemistry.
[152] Eunjoon Kim,et al. Characterization of the Shank Family of Synaptic Proteins , 1999, The Journal of Biological Chemistry.
[153] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[154] Y. Hata,et al. Synamon, a Novel Neuronal Protein Interacting with Synapse-associated Protein 90/Postsynaptic Density-95-associated Protein* , 1999, The Journal of Biological Chemistry.
[155] T. Boeckers,et al. Proline-Rich Synapse-Associated Protein-1/Cortactin Binding Protein 1 (ProSAP1/CortBP1) Is a PDZ-Domain Protein Highly Enriched in the Postsynaptic Density , 1999, The Journal of Neuroscience.
[156] P. Worley,et al. Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins , 1999, Neuron.
[157] P. Worley,et al. Shank, a Novel Family of Postsynaptic Density Proteins that Binds to the NMDA Receptor/PSD-95/GKAP Complex and Cortactin , 1999, Neuron.
[158] W. Brown,et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.
[159] D. J. Driscoll,et al. Molecular mechanism of angelman syndrome in two large families involves an imprinting mutation. , 1999, American journal of human genetics.
[160] D. Linden,et al. Homer Binds a Novel Proline-Rich Motif and Links Group 1 Metabotropic Glutamate Receptors with IP3 Receptors , 1998, Neuron.
[161] S. Weed,et al. Identification of a Novel Cortactin SH3 Domain-Binding Protein and Its Localization to Growth Cones of Cultured Neurons , 1998, Molecular and Cellular Biology.
[162] A. Bird,et al. Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.
[163] J. Strouboulis,et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.
[164] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[165] Stephen J. Guter,et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. , 1998, American journal of human genetics.
[166] T. Südhof,et al. Neurexins: three genes and 1001 products. , 1998, Trends in genetics : TIG.
[167] T. Südhof,et al. Binding of neuroligins to PSD-95. , 1997, Science.
[168] I. Weiler,et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[169] M. Lalande,et al. UBE3A/E6-AP mutations cause Angelman syndrome , 1996, Nature Genetics.
[170] Ping Fang,et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome , 1997, Nature Genetics.
[171] T. Südhof,et al. CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[172] T. Südhof,et al. Structures, Alternative Splicing, and Neurexin Binding of Multiple Neuroligins (*) , 1996, The Journal of Biological Chemistry.
[173] Raoul C. M. Hennekam,et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.
[174] T. Südhof,et al. Neuroligin 1: A splice site-specific ligand for β-neurexins , 1995, Cell.
[175] B. Hagberg. Clinical Delineation of Rett Syndrome Variants , 1995, Neuropediatrics.
[176] D. Kwiatkowski,et al. Tuberous sclerosis. , 1994, Archives of dermatology.
[177] J. Clayton-Smith,et al. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. , 1993, American journal of medical genetics.
[178] A. Bird,et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.
[179] J. Sutcliffe,et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.
[180] J. Sutcliffe,et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.
[181] J. Knoll,et al. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome , 1989, Nature.
[182] M. Bear,et al. Visual experience regulates gene expression in the developing striate cortex. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[183] D. Ledbetter,et al. Uniparental disomy as a mechanism for human genetic disease. , 1988, American journal of human genetics.
[184] D. Ledbetter,et al. Is Angelman syndrome an alternate result of del(15)(q11q13)? , 1987, American journal of medical genetics.
[185] W. Travis,et al. A Report of Three Cases , 1986 .
[186] J. Opitz,et al. Consideration of connective tissue dysfunction in the fragile X syndrome. , 1984, American journal of medical genetics.
[187] Jean Aicardi,et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases , 1983, Annals of neurology.
[188] C. Harrison,et al. The fragile X: a scanning electron microscope study. , 1983, Journal of medical genetics.
[189] C. F. von Reyn,et al. Infection of an infant with an adult Toxocara cati (Nematoda). , 1978, The Journal of pediatrics.
[190] S. Pelc,et al. [Happy-puppet syndrome]. , 1976, Helvetica paediatrica acta.
[191] H. Lubs. A marker X chromosome. , 1969, American journal of human genetics.
[192] A Rett,et al. [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. , 1966, Wiener medizinische Wochenschrift.
[193] Harry Angelman,et al. ‘Puppet’ Children A Report on Three Cases , 1965 .
[194] J. Bell,et al. A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE , 1943, Journal of neurology and psychiatry.
[195] D. M. Bourneville. Sclerose tubereuse des circonvolutions cerebrales : idiotie et epilepsie hemiplegique , 1880 .